Stay updated on CDX-0159 in Prurigo Nodularis Clinical Trial
Sign up to get notified when there's something new on the CDX-0159 in Prurigo Nodularis Clinical Trial page.

Latest updates to the CDX-0159 in Prurigo Nodularis Clinical Trial page
- Check5 days agoChange DetectedA banner announces NIH’s website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check12 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check18 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1. The page displays a 403 Forbidden response instead of the study record.SummaryDifference0.2%

- Check39 days agoChange DetectedThe study record page now displays a 403 Forbidden error, replacing the full set of trial details with an error screen.SummaryDifference17%

- Check60 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a newer build or deployment of the page. This appears to be a minor update to the page or UI rather than a substantive alteration of the study details.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision v3.6.5 was applied, replacing v3.6.4, signaling a minor update to the page's underlying platform.SummaryDifference0.1%

Stay in the know with updates to CDX-0159 in Prurigo Nodularis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CDX-0159 in Prurigo Nodularis Clinical Trial page.